S. Goldberg
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
-
- Immunotherapy and Immune Responses 6
- T-cell and B-cell Immunology 4
- Immune Cell Function and Interaction 3
- Oncology 4
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 3
- Co-authors
- Jedd D. Wolchok (7 shared papers)Alan N. Houghton (6 shared papers)Mary Jo Turk (4 shared papers)José A. Guevara-Patiño (2 shared papers)Miguel‐Angel Perales (4 shared papers)Cristina R. Ferrone (2 shared papers)Manuel E. Engelhorn (1 shared paper)Rodica Stan (1 shared paper)
- Journals
- Journal of Clinical Oncology (7 papers)Clinical Cancer Research (2 papers)Journal of Thoracic Oncology (1 paper)Immunity (1 paper)Advances in immunology (1 paper)
- Partner nations
- United StatesItalySpain
In The Last Decade
S. Goldberg
15 papers receiving 428 citations
Peers
Comparison fields: 5 of 60
- Immunology 288
- Oncology 182
- Hematology 37
- Genetics 32
- Radiology, Nuclear Medicine and Imaging 63
Countries citing papers authored by S. Goldberg
This map shows the geographic impact of S. Goldberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Goldberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Goldberg more than expected).
Fields of papers citing papers by S. Goldberg
This network shows the impact of papers produced by S. Goldberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Goldberg. The network helps show where S. Goldberg may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Goldberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 68 | |
| 2 | 2002 | 59 | |
| 3 | Randomized phase I pharmacokinetic study of ipilimumab with or without one of two different chemotherapy regimens in patients with untreated advanced melanoma. | 2013 | 58 |
| 4 | 2006 | 54 | |
| 5 | 2005 | 48 | |
| 6 | 2006 | 41 | |
| 7 | 2002 | 27 | |
| 8 | 2012 | 22 | |
| 9 | 2006 | 20 | |
| 10 | 2013 | 13 | |
| 11 | 2013 | 10 | |
| 12 | 2005 | 9 | |
| 13 | 2011 | 6 | |
| 14 | 2010 | 3 | |
| 15 | 2018 | 1 |
About S. Goldberg
S. Goldberg is a scholar working on Immunology, Oncology, Genetics, Hematology and Pathology and Forensic Medicine, having authored 15 papers that have together received 439 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (6 papers), T-cell and B-cell Immunology (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), CAR-T cell therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Immunology (288 citations), Oncology (182 citations), Hematology (37 citations), Genetics (32 citations) and Radiology, Nuclear Medicine and Imaging (63 citations). S. Goldberg has collaborated with scholars based in United States, Italy and Spain. Frequent co-authors include Jedd D. Wolchok, Alan N. Houghton, Mary Jo Turk, José A. Guevara-Patiño, Miguel‐Angel Perales, Cristina R. Ferrone, Manuel E. Engelhorn, Rodica Stan, Omid Hamid and Gabrielle Rizzuto. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Journal of Thoracic Oncology, Immunity and Advances in immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.